Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared M Weiss

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer|May 6, 2021
Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m<sup>2</sup> ?Jared M Weiss
The Oncologist|August 7, 2013
Second-Line Therapy for Advanced NSCLCJared M Weiss, Thomas E Stinchcombe
Lung Cancer (Amsterdam, Netherlands)|September 10, 2014
A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapyJared M Weiss, Liza C Villaruz, Mark A Socinski, et al.
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Clinical Lung Cancer|January 18, 2016
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung CancerJared M Weiss, Liza C Villaruz, Jonathon O'Brien, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 8, 2022
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care TherapyAlexander T Murr, Nicholas R Lenze, Jared M Weiss, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapyAnne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Cancer|August 11, 2021
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinomaBhishamjit S Chera, Siddharth H Sheth, Shetal A Patel, et al.
Cancer|May 10, 2018
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neckJared M Weiss, Juneko E Grilley-Olson, Allison Mary Deal, et al.
Advances in Radiation Oncology|July 26, 2017
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility studyAaron D Falchook, Gregg Tracton, Lori Stravers, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer|May 6, 2021
Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m<sup>2</sup> ?Jared M Weiss
The Oncologist|August 7, 2013
Second-Line Therapy for Advanced NSCLCJared M Weiss, Thomas E Stinchcombe
Lung Cancer (Amsterdam, Netherlands)|September 10, 2014
A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapyJared M Weiss, Liza C Villaruz, Mark A Socinski, et al.
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Clinical Lung Cancer|January 18, 2016
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung CancerJared M Weiss, Liza C Villaruz, Jonathon O'Brien, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 8, 2022
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care TherapyAlexander T Murr, Nicholas R Lenze, Jared M Weiss, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapyAnne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Cancer|August 11, 2021
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinomaBhishamjit S Chera, Siddharth H Sheth, Shetal A Patel, et al.
Cancer|May 10, 2018
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neckJared M Weiss, Juneko E Grilley-Olson, Allison Mary Deal, et al.
Advances in Radiation Oncology|July 26, 2017
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility studyAaron D Falchook, Gregg Tracton, Lori Stravers, et al.
Pageof 2